Spero Therapeutics, Inc.
NASDAQ:SPRO
1.37 (USD) • At close September 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||
| Current Assets: | |||||||||
| Cash & Cash Equivalents
| 76.333 | 109.107 | 112.584 | 85.209 | 29.73 | 34.08 | 87.288 | 10.315 | 5.691 |
| Short Term Investments
| 0 | 0 | 33.818 | 41.697 | 52.315 | 81.363 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 76.333 | 109.107 | 146.402 | 126.906 | 82.045 | 115.443 | 87.288 | 10.315 | 5.691 |
| Net Receivables
| 50.697 | 1.084 | 2.641 | 6.176 | 8.546 | 1.298 | 2.943 | 0.304 | 0.01 |
| Inventory
| 0 | -4.463 | 0 | -12.239 | -13.369 | -8.776 | -4.771 | 0 | 0 |
| Other Current Assets
| 4.178 | 3.379 | 8.829 | 6.063 | 4.823 | 7.478 | 1.828 | 1.253 | 0.287 |
| Total Current Assets
| 131.208 | 109.107 | 157.872 | 126.906 | 82.045 | 115.443 | 87.288 | 11.872 | 5.988 |
| Non-Current Assets: | |||||||||
| Property, Plant & Equipment, Net
| 4.157 | 5.492 | 7.556 | 8.783 | 7.148 | 2.893 | 1.164 | 1.5 | 0.949 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 46.59 | 0 | 0 | 0 | 0.021 | 0.233 | 0.05 | 0.05 | 0.05 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.435 | 10.203 | 5.644 | 17.762 | 16.889 | 10.437 | 4.977 | 0.35 | 0.189 |
| Total Non-Current Assets
| 51.182 | 15.695 | 13.2 | 26.545 | 24.058 | 13.563 | 6.191 | 1.9 | 1.188 |
| Total Assets
| 182.39 | 124.802 | 171.072 | 153.451 | 106.103 | 129.006 | 93.479 | 13.772 | 7.176 |
| Liabilities & Equity: | |||||||||
| Current Liabilities: | |||||||||
| Account Payables
| 1.378 | 0.617 | 1.101 | 1.155 | 4.147 | 3.603 | 3.47 | 1.139 | 1.794 |
| Short Term Debt
| 1.718 | 1.69 | 1.362 | 0.947 | 0.928 | 0 | 0 | 0 | 0.731 |
| Tax Payables
| 0.387 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 27.113 | 10.369 | 1.857 | 0 | 0 | 0 | 0 | 0 | 0.512 |
| Other Current Liabilities
| 6.944 | 8.973 | 14.35 | 12.241 | 21.588 | 8.715 | 4.687 | 5.779 | 3.384 |
| Total Current Liabilities
| 37.153 | 21.649 | 18.67 | 14.343 | 26.663 | 12.318 | 8.157 | 6.918 | 6.421 |
| Non-Current Liabilities: | |||||||||
| Long Term Debt
| 3.825 | 4.957 | 5.973 | 6.891 | 4.617 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 34.431 | 22.166 | 8.786 | 0 | 0 | 0 | 0 | 0 | 0.417 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0.802 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0.087 | 0.096 | 48.552 | 0.177 | 0.249 | 0.833 | 0.365 | 0.493 | 0.595 |
| Total Non-Current Liabilities
| 38.343 | 27.219 | 64.113 | 7.068 | 4.866 | 0.833 | 0.365 | 0.493 | 1.012 |
| Total Liabilities
| 75.496 | 48.868 | 82.783 | 21.411 | 31.529 | 13.151 | 8.522 | 7.411 | 7.433 |
| Equity: | |||||||||
| Preferred Stock
| 0 | 0 | 0.003 | 0.003 | 0 | 0 | 93.479 | 47.685 | 18.296 |
| Common Stock
| 0.053 | 0.052 | 0.032 | 0.029 | 0.019 | 0.017 | 0.014 | 7.924 | 0 |
| Retained Earnings
| -391.072 | -413.878 | -367.463 | -277.707 | -199.427 | -138.502 | -96.84 | -45.44 | -18.1 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 0 | -0.002 | -0.007 | 0.016 | -0.028 | -0.643 | -0.29 | -0.011 |
| Other Total Stockholders Equity
| 497.913 | 489.76 | 455.719 | 409.722 | 273.966 | 254.368 | 88.947 | 0.29 | 0.011 |
| Total Shareholders Equity
| 106.894 | 75.934 | 88.289 | 132.04 | 74.574 | 115.855 | 84.957 | 10.169 | 0.196 |
| Total Equity
| 106.894 | 75.934 | 88.289 | 132.04 | 74.574 | 116.21 | 85.312 | 6.361 | -0.257 |
| Total Liabilities & Shareholders Equity
| 182.39 | 124.802 | 171.072 | 153.451 | 106.103 | 129.006 | 93.479 | 13.772 | 7.176 |